Cargando…
ALDOB plays a tumor-suppressive role by inhibiting AKT activation in gastric cancer
Abstract: Enhanced aerobic glycolysis has been one of the cancer hallmarks. Cancerous cells develop certain alterations during glucose metabolism for supporting their infinite growth requirement and metastasis. Therefore, targeting metabolism, for instance, crucial glycolytic enzymes, will provide a...
Autores principales: | Peng, Chaozhong, Yang, Xuan, Li, Xiao, Ye, Zhixue, Wang, Jiangming, Wu, Wenqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414037/ https://www.ncbi.nlm.nih.gov/pubmed/37576390 http://dx.doi.org/10.7150/jca.83456 |
Ejemplares similares
-
Downregulation of ALDOB is associated with poor prognosis of patients with gastric cancer
por: He, Jun, et al.
Publicado: (2016) -
Rab1A promotes cell proliferation and migration by upregulating Gli1 in colorectal cancer
por: Peng, Chaozhong, et al.
Publicado: (2021) -
Loss of hepatic aldolase B activates Akt and promotes hepatocellular carcinogenesis by destabilizing the Aldob/Akt/PP2A protein complex
por: He, Xuxiao, et al.
Publicado: (2020) -
Prognostic values of ALDOB expression and (18)F-FDG PET/CT in hepatocellular carcinoma
por: Jia, Wenzhi, et al.
Publicado: (2022) -
ALDOB represents a potential prognostic biomarker for patients with clear cell renal cell carcinoma
por: Shao, Yuan, et al.
Publicado: (2023)